drugset / Trial / NCT01050751
Bioavailability Of Lersivirine Single 750 Mg Tablet Versus 3 X 250 Mg Tablets
RandomizedCrossoverOpen-labelTreatment
Summary
This is a randomized study to assess whether the pharmacokinetics of a new single 750 mg tablet is similar to 3 x 250 mg tablets (750 mg total).
Timeline
- Start
- 2010-02
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lersivirine | Small molecule | 750 mg | Oral |
Indications
No indication recorded.